| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.6M | -14.7% |
| Cost of Revenue | $48.2M | -1.3% |
| Gross Profit | $6.4M | -57.8% |
| R&D Expense | $17.7M | +9.1% |
| SG&A Expense | $10.3M | +4.6% |
| Operating Income | -$38.0M | -29.9% |
| Pre-tax Income | -$38.5M | -26.3% |
| Income Tax | $167K | +132.1% |
| Net Income | -$38.6M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.2M | -49.3% |
| Accounts Receivable | $10.8M | +134.6% |
| Inventory | $5.5M | -51.1% |
| Current Assets | $35.7M | -21.7% |
| Total Assets | $41.1M | -18.3% |
| Current Liabilities | $21.0M | +2.5% |
| Long-term Debt | $66K | -81.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.5M | -264.4% |
| Capital Expenditures | $46K | +318.2% |
| Investing Cash Flow | -$46K | -318.2% |
| Financing Cash Flow | $27.6M | +29.0% |
| Free Cash Flow | -$38.5M | -264.4% |
| -29.0% |
| Total Liabilities |
| $22.5M |
| +2.5% |
| Stockholders' Equity | $18.6M | -34.4% |